Ariadne Wealth Management’s Gilead Sciences GILD Stock Holding History

Ariadne Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$791K	Sell	5,675 -1,004	-15%	-$141K	0.36%	67
2025 Q4	$1.01M	Buy	6,679 +523	+8%	+$63.6K	0.42%	53
2025 Q3	$771K	Sell	6,156 -289	-4%	-$32.8K	0.35%	64
2025 Q2	$774K	Sell	6,445 -264	-4%	-$28.1K	0.37%	58
2025 Q1	$650K	Buy	6,709 +49	+0.7%	+$5.06K	0.34%	65
2024 Q4	$636K	Buy	6,660 +737	+12%	+$66.4K	0.29%	70
2024 Q3	$580K	Buy	+5,923	New	+$452K	0.32%	58

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ariadne Wealth Management's GILD Position: Q1 2026 in Review

Ariadne Wealth Management reduced its Gilead Sciences (GILD) stake by 15% in Q1 2026, selling an estimated $141K and leaving 5,675 shares worth $791K. The position accounts for 0.36% of the portfolio, ranked #67.

Ariadne Wealth Management first reported a position in GILD in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.01M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Ariadne Wealth Management held 5,675 shares of Gilead Sciences worth $791K as of Q1 2026.
Ariadne Wealth Management sold 1,004 Gilead Sciences shares in Q1 2026, an estimated $141K.
Gilead Sciences made up 0.36% of Ariadne Wealth Management's portfolio in Q1 2026, its #67 holding.
Ariadne Wealth Management first reported a position in Gilead Sciences in Q3 2024 and has held it in 7 quarters since.
Ariadne Wealth Management's Gilead Sciences position peaked at $1.01M in Q4 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Ariadne Wealth Management's 13F filing for Q1 2026, filed 18 May 2026.